Schedule 13D ownership disclosure

Immunovant Inc

Common Stock, par value $0.0001 per share · CUSIP: 45258J102

Event date: 2025-12-12

Filing-level shares
113,327,007
Percent of class
55.9%
  • Roivant Sciences Ltd.Reported CIK 0001635088

    Shares: 113,327,007 · Class: 55.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-045411
Form type
SCHEDULE 13D/A
Filer
Immunovant, Inc.
CIK
CIK 1764013
Filed
Dec 12, 2025
Reporting period
Dec 12, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub